BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
1.810
-0.050 (-2.69%)
At close: Nov 20, 2026, 4:00 PM EST
1.840
+0.030 (1.66%)
After-hours: Nov 20, 2026, 5:33 PM EST
BBOT Market Cap
BBOT has a market cap or net worth of $145.25 million as of November 20, 2026. It is the 22,072nd most valuable company in the world and the 3,704th biggest in the United States. Its market cap has decreased by 85.68% in one year.
Market Cap
145.25M
Enterprise Value
-167.70M
1-Year Change
-85.68%
Global Rank
Country Rank
#3,704 United States
Category
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $145.25M, an increase of 280.12%. That is a compound annual growth rate of 61.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 145.25M | -85.50% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 156.01M |
| ProQR Therapeutics | 155.23M |
| Veraxa Biotech AG | 145.65M |
| Protara Therapeutics | 144.07M |
| Atrium Therapeutics | 143.23M |
| Sutro Biopharma | 141.11M |
| Invivyd | 139.09M |
| Humacyte | 138.90M |